Retail network access is facilitated through agreements with United Networks of America (UNA). Display of pharmacy brand marks does not imply ownership, endorsement, or direct partnership with XRP Healthcare M&A Holding Inc.
Technology partnerships reflect collaborative or project-based cooperation. Display does not imply equity ownership or endorsement unless expressly stated.
Pharmaceutical and supply relationships reflect existing commercial arrangements within acquired operating entities. Display does not imply exclusivity or endorsement beyond standard commercial supply agreements.
Advisors provide professional services to XRP Healthcare M&A Holding Inc. No partnership or ownership interest is implied unless publicly disclosed.
All third-party trademarks remain the property of their respective owners. Display does not imply endorsement, ownership, or partnership unless expressly stated.
Jul 2, 2025
As the second half of 2025 unfolds, XRP Healthcare enters Q3 not just with intention - but with undeniable momentum.

As the second half of 2025 unfolds, XRP Healthcare enters Q3 not just with intention - but with undeniable momentum.
Positioned for a proposed public listing on the TSX Venture Exchange, the company is no longer simply preparing for growth - it is actively experiencing it. The IPO is more than a milestone; it reflects relentless execution, strategic positioning, and a long-term commitment to solving real healthcare challenges across emerging markets.
Over recent months, XRP Healthcare has taken decisive steps forward. Strategic acquisitions, expansion into new territories, and the rollout of AI-powered healthcare solutions are redefining what is possible in regions historically underserved by traditional healthcare systems.
But this vision extends beyond digital healthcare alone. With operational pharmacies now active across East Africa, alongside the deployment of intelligent triage and referral platforms, XRP Healthcare is combining physical healthcare infrastructure with advanced technology to create a scalable and impactful ecosystem.
This quarter marks more than simple continuation - it signals transformation.
Q3 is where preparation begins translating into measurable impact. As institutional interest continues to grow and operational milestones accelerate, XRP Healthcare is uniquely positioned to elevate private healthcare delivery across fast-growing, high-demand regions.
This is no longer merely a startup story - it is a movement building real momentum.
If the first half of 2025 focused on laying the foundation, Q3 is about building upon it. The groundwork is established. The model is validated. The mission is already in motion.
This is not simply another promising chapter - it may become the defining phase that shapes everything ahead.